China Reform Conson Soochow Overseas Fund I L.P.
Overview
China Reform Conson Soochow Overseas Fund I L.P. is a private equity fund solely advised by CDG Capital that invests in the healthcare, high-end manufacturing, and TMT sectors.
Portfolio Companies
1
Website
cdgcapital.comInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Xingeyuan Biotechnology | Sep 2020 | Series A | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is China Reform Conson Soochow Overseas Fund I L.P. based?
China Reform Conson Soochow Overseas Fund I L.P. is headquartered in Hong Kong, Hong Kong.
When was China Reform Conson Soochow Overseas Fund I L.P. founded?
Founding year information for China Reform Conson Soochow Overseas Fund I L.P. is not publicly available.
How many portfolio companies does China Reform Conson Soochow Overseas Fund I L.P. have?
China Reform Conson Soochow Overseas Fund I L.P. has 1 portfolio company in Caplight's dataset.
What are some companies in China Reform Conson Soochow Overseas Fund I L.P.'s portfolio?
Recent investments visible on Caplight include Xingeyuan Biotechnology.
What was China Reform Conson Soochow Overseas Fund I L.P.'s most recent investment?
China Reform Conson Soochow Overseas Fund I L.P.'s most recent investment on Caplight was in Xingeyuan Biotechnology in 2020.
What sectors does China Reform Conson Soochow Overseas Fund I L.P. focus on?
China Reform Conson Soochow Overseas Fund I L.P. focuses on Healthcare & Life Sciences.
What company stages does China Reform Conson Soochow Overseas Fund I L.P. focus on?
China Reform Conson Soochow Overseas Fund I L.P. typically invests at the Early stage.